1. Background of the team and purpose of the role
In the context of limited global supply, an ‘Allocation Mechanism’ is being established to deliver on the Fair Allocation Framework, comprising of an expert Independent Allocation Validation Group (IAVG) and a Joint Allocation Taskforce (JAT). The JAT, comprised of staff from WHO and Gavi, supports the IAVG, and its functions are to:
§ develop Vaccine Allocation Decision (VAD) proposals, based on a data-driven model, for review and validation by the IAVG
§ work with the Office of the COVAX Facility within Gavi to ensure implementation of the validated VAD
§ support the maintenance of the Allocation Model
§ provide secretariat support to the IAVG
§ coordinate and communicate with all COVAX Partners
§ ensure transparency on the Allocation Mechanism and decisions from the IAVG to all COVAX participating countries through the COVAX Facility governance bodies
The main purpose of the IAVG is to validate proposals for Vaccine Allocation Decisions (“VAD proposals”) prepared by the JAT outlining the volumes of vaccines to be allocated to each participant of the COVAX Facility within a given time frame, depending on supply forecasts.
As a member of the Joint Allocation Taskforce, the Technical Officer will be a key contributor to the Joint Allocation Taskforce by developing Vaccine Allocation Decision (VAD) proposals for validation by the Independent Allocation Validation Group and by working closely with the Office of the COVAX Facility to ensure implementation of the validated proposals.
2. Description of Services:
The Technical Officer will be responsible for managing the process of vaccine donation allocations. He/she will own the analyses that determine which recipient countries should be prioritised for doses and will coordinate across COVAX teams to collect data inputs and verify allocation outputs.
Main Duties & Responsibilities:
Specific duties include:
· Assist in the preparation of analyses and data models to aid in high-level decision making for key governance meetings, ensuring collection of data inputs and assumptions from different organizations / stakeholders.
Note: The essential functions listed in this section are not exhaustive of the job responsibilities; other duties may be assigned consistently with the department needs.
3. Location: Gavi Alliance HQ, Geneva, Switzerland or remote (subject to discussion).
4. Qualifications and work experience required:
Academic
Work Experience
Skills/competencies
Note: short-listed candidates may be asked to complete a timed test to demonstrate their data management, analysis and communication skills.
Languages:
5. Duration of Assignment: as soon as possible through to end December 2022.
6. Selection Process and expected timelines
We are committed to fostering a just, equitable and diverse culture free from racism and discrimination in which all staff, partners and stakeholders feel empowered, safe, and heard.
If you wish to apply, please visit our Careers webpage and apply by sending your application to procurement@gavi.org with the title 191-2021-GAVI-RFQ - Technical Officer, Joint Allocation Taskforce - Dose Sharing before the closing date of 1 December 2021.
1. Background and Introduction
Gavi, the Vaccine Alliance is a public-private partnership committed to saving children's lives and protecting people's health by increasing equitable use of vaccines in lower-income countries. The Vaccine Alliance brings together implementing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. Gavi uses innovative finance mechanisms, including co-financing by recipient countries, to secure sustainable funding and adequate supply of quality vaccines. Since 2000, Gavi has contributed to the immunisation of more than 888 million children and the prevention of more than 15 million future deaths.
The COVAX Facility (“COVAX”) provides a global solution to the equitable distribution of vaccines to the 190 participating countries and economies. The COVAX Advance Market Commitment (AMC) is an innovative financing instrument that supports the participation of the 92 low and lower-middle income economies in COVAX. Self-financing participants (SFPs) have entered COVAX either as Optional (having the possibility to opt-out of a particular vaccine) or Committed Purchasers. Guided by the WHO fair allocation framework, COVAX will equitably distribute doses to help protect the most at-risk groups. Gavi is working with Alliance partners UNICEF and WHO to ensure that the infrastructure is in place, and the technical support available, for COVID-19 vaccines to be safely delivered to all those who need them.